These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22318091)

  • 21. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
    Palmqvist P; Lundberg P; Persson E; Johansson A; Lundgren I; Lie A; Conaway HH; Lerner UH
    J Biol Chem; 2006 Feb; 281(5):2414-29. PubMed ID: 16251181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
    Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
    J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-α suppression and osteoprotegerin overexpression inhibits wear debris-induced inflammation and osteoclastogenesis in vitro.
    Peng L; Zhang H; Zhou Y; Li W; Jiang P; Zhang Y; Song K
    Int J Artif Organs; 2015 Oct; 38(10):565-71. PubMed ID: 26541276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model.
    Yang S; Wu B; Mayton L; Evans CH; Robbins PD; Wooley PH
    Inflamm Res; 2002 Jul; 51(7):342-50. PubMed ID: 12146725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin.
    Crotti TN; Smith MD; Findlay DM; Zreiqat H; Ahern MJ; Weedon H; Hatzinikolous G; Capone M; Holding C; Haynes DR
    Biomaterials; 2004 Feb; 25(4):565-73. PubMed ID: 14607494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netrin-1 regulates ERK1/2 signaling pathway and autophagy activation in wear particle-induced osteoclastogenesis.
    Wang L; Gao Z; Zhang J; Huo Y; Xu Q; Qiu Y
    Cell Biol Int; 2021 Mar; 45(3):612-622. PubMed ID: 33386763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strontium ranelate inhibits titanium-particle-induced osteolysis by restraining inflammatory osteoclastogenesis in vivo.
    Liu X; Zhu S; Cui J; Shao H; Zhang W; Yang H; Xu Y; Geng D; Yu L
    Acta Biomater; 2014 Nov; 10(11):4912-4918. PubMed ID: 25078426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model.
    Zhou CH; Shi ZL; Meng JH; Hu B; Zhao CC; Yang YT; Yu W; Chen ZX; Heng BC; Parkman VA; Jiang S; Zhu HX; Wu HB; Shen WL; Yan SG
    Br J Pharmacol; 2018 Mar; 175(6):859-876. PubMed ID: 29130485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
    Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
    Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages.
    Choe JY; Kim SK
    Int J Mol Med; 2017 Mar; 39(3):539-548. PubMed ID: 28204822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.
    Gehrke T; Sers C; Morawietz L; Fernahl G; Neidel J; Frommelt L; Krenn V
    Scand J Rheumatol; 2003; 32(5):287-94. PubMed ID: 14690142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.
    Yang C; Liu W; Zhang X; Zeng B; Qian Y
    J Orthop Surg Res; 2020 Dec; 15(1):600. PubMed ID: 33302980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway.
    Yang H; Xu Y; Zhu M; Gu Y; Zhang W; Shao H; Wang Y; Ping Z; Hu X; Wang L; Geng D
    Biomaterials; 2016 Feb; 80():1-10. PubMed ID: 26695376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
    Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
    Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibitory effect of strontium-doped calcium polyphosphate particles on cytokines from macrophages and osteoblasts leading to aseptic loosening in vitro.
    Huang C; Li L; Yu X; Gu Z; Zhang X
    Biomed Mater; 2014 Apr; 9(2):025010. PubMed ID: 24518283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
    Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
    Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
    Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
    Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spinal implant debris-induced osteolysis.
    Hallab NJ; Cunningham BW; Jacobs JJ
    Spine (Phila Pa 1976); 2003 Oct; 28(20):S125-38. PubMed ID: 14560184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.